NCT00166725 Effects of Octreotide Acetate on Circulating Levels of Chromogranin A in Advanced Prostate Cancer Patients Status COMPLETED Phase PHASE2
NCT00164008 Comparison of Pamidronate With Zoledronic Acid for Transplant Related Bone Loss Prevention Status COMPLETED Phase PHASE4
NCT00160966 Impact of Immunosuppressive Regimens on Polyomavirus-related Transplant Nephropathy Status COMPLETED Phase PHASE4
NCT00159484 Phase I/II Study of Celebrex and EPO906 in Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00159016 Role of Glivec in Patients With Tumor Cells Positive for C-kit or PDGFR; a Multi Center Study. Status WITHDRAWN Phase PHASE2
NCT00154362 The Efficacy and Safety of Oral Oxcarbazepine 300-1200 mg/Day as Adjuvant Therapy in the Treatment of Adolescents With Impulsivity and Aggressive Behavior in Conduct Disorder This Study is Not Being Conducted in the United States. Status COMPLETED Phase PHASE4
NCT00154323 The Efficacy and Safety of Oral Oxcarbazepine 300-1200 mg/Day as Adjuvant Therapy in the Treatment of Bipolar Disorder I or II This Study is Not Being Conducted in the United States. Status COMPLETED Phase PHASE4
NCT00154310 Efficacy and Safety of Everolimus With Enteric-Coated Mycophenolate Sodium (EC-MPS) in a Cyclosporine Microemulsion-free Regimen Compared to Standard Therapy in de Novo Renal Transplant Patients Status COMPLETED Phase PHASE4
NCT00154284 Everolimus in a Cyclosporine Microemulsion-free Regimen Compared to a Low-dose Cyclosporine Microemulsion Regimen, in de Novo Kidney Transplant Patients Status COMPLETED Phase PHASE3
NCT00154271 Effects of Blood Pressure Reduction on High Sensitivity C-Reactive Protein (hsCRP) Status COMPLETED Phase PHASE4
NCT00154258 A Long Term Study of Clozapine in Patients With Treatment-resistant Schizophrenia Status COMPLETED Phase PHASE2
NCT00154245 A One-year, Open Label Study to Investigate the Safety and the Effect of Enteric-coated Mycophenolate Sodium (EC-MPS) in Combination With Cyclosporine Microemulsion in de Novo Kidney Transplant Recipients. Status COMPLETED Phase PHASE4
NCT00154219 Efficacy and Safety Study of Lumiracoxib in Patients With Primary Hip Osteoarthritis Status COMPLETED Phase PHASE3
NCT00151671 Effect of a Perioperative Oral Nutritional Supplementation on Patients Undergoing Hepatic Surgery for Liver Cancer Status TERMINATED Phase PHASE2/PHASE3
NCT00151073 Estramustine, Docetaxel and Zoledronate Treatment in Hormone-Refractory Adenocarcinoma of the Prostate Status COMPLETED Phase PHASE2
NCT00150891 Th1, Th2 and Monokine Responses as Risk Factors of Renal Transplant Rejection Status COMPLETED Phase N/A
NCT00150085 Safety and Efficacy of Converting Maintenance Kidney and Liver Transplant Recipients With Abnormal Glucose Metabolism From Tacrolimus to Cyclosporine Micro-emulsion Status TERMINATED Phase PHASE4